Skip to content
Abierto
Menu

Award notice

Development of Medical Countermeasures for Biodefense and Emerging Infectious Diseases

7529

National Institutes of Health, National Institutes of Health Niaid.

View on SAM.govMarkdown

Awarded

Genomic Labs Ltd.

$3,490,083.00 on the award notice, September 29, 2025, contract 75N93025C00025

Description

As published on SAM.gov.

This cost-reimbursement contract award was made under full and open competition. This type of contract was selected because costs cannot be adequately defined at the time of contract award.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Genomic Labs Ltd.
UEI
NGZ6HVXE5MX4
CAGE
U1PX6
Vendor location
Bristol
Contract
75N93025C00025, definitive contract
Obligated
$1,000,000.00, potential $3,490,083
Actions
1 between September 29, 2025 and September 29, 2025
Competition
Full and Open Competition, 41 offers received
Set-aside reported
No Set Aside Used.
Described as
To Develop an Integrated Diagnostic Platform That Utilizes Whole Genome Sequencing (Wgs) to Identify Bacterial Pathogens and Predict Antibiotic Susceptibility Directly from Blood, Within a Few Hours - Addressing Limitations with Current Culture-Based
Match
award number 75N93025C00025 equals the contract number; same awarding office 75N930 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. December 21, 2025

    Award notice

    Awarded to GENOMIC LABS Ltd. Bristol BS2 0JZ GBR for $3,490,083. SAM.gov, notice 5e2cc96d8eac49db8e46250ccce669a4

Also open from this buyer